Giovanni Battista Giovenzana

Prof. Giovanni Battista Giovenzana

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2017 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
GNGábor Nagy
Gábor Nagy
DSDezső Szikra
Dezső Szikra
GTGyörgy Trencsényi
György Trencsényi
AFAnikó Fekete
Anikó Fekete
IGIldikó Garai
Ildikó Garai
ZBZsolt Baranyai
Zsolt Baranyai

1 January 2016 in Biomaterials
Verified
Journal Article
Closed access
DLDario Longo
Dario Longo
FAFrancesca Arena
Francesca Arena
LCLorena Consolino
Lorena Consolino
PMPaolo Minazzi
Paolo Minazzi
SCSimonetta Geninatti Crich
Simonetta Geninatti Crich
SASilvio Aime
Silvio Aime

18 May 2018 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
GRGabriele Rolla
Gabriele Rolla
VBValeria De Biasio
Valeria De Biasio
Giovanni Battista GiovenzanaGiovanni Battista Giovenzana
Giovanni Battista Giovenzana
MBMauro Botta
Mauro Botta
LTLorenzo Tei
Lorenzo Tei
The Mn2+ complexes of amphiphilic derivatives of EDTA and 1,4-DO2A ligands show a strong increase in relaxivity upon micellar aggregation and human serum albumin binding.

22 March 2008 in Inorganic Chemistry
Verified
Journal Article
Closed access
DCdaniela delli castelli
daniela delli castelli
ETEnzo Terreno
Enzo Terreno
CCCarla Carrera
Carla Carrera
Giovanni Battista GiovenzanaGiovanni Battista Giovenzana
Giovanni Battista Giovenzana
RMRoberta Mazzon
Roberta Mazzon
SASilvio Aime
Silvio Aime

9 July 2021 in Inorganic Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
DHDávid Horváth
Dávid Horváth
FTFabio Travagin
Fabio Travagin
NGNicol Guidolin
Nicol Guidolin
FBFederica Buonsanti
Federica Buonsanti
GTGyula Tircsó
Gyula Tircsó
ZBZsolt Baranyai
Zsolt Baranyai
Bi III -DOTP complex is characterised by a fast formation kinetics, an outstanding thermodynamic stability and an impressive kinetic interness, making Bi III -DOTP an optimal model for the development of targeted α-therapy (TAT) radiopharmaceuticals.

11 January 2021 in Inorganic Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
LLLuciano Lattuada
Luciano Lattuada
DHDávid Horváth
Dávid Horváth
SSSonia Colombo Serra
Sonia Colombo Serra
AMAlberto Fringuello Mingo
Alberto Fringuello Mingo
PMPaolo Minazzi
Paolo Minazzi
ZBZsolt Baranyai
Zsolt Baranyai
Gadolinium(III) complexes have been employed for more than 30 years as contrast agents in magnetic resonance imaging (MRI). In order to further improve the diagnostic accuracy of enhanced magnetic resonance images or to provide comparable enhancement at a reduced administered dose, current research is focusing on the development of GdIII-complexes characterized by higher relaxivity. In this study we describe the synthesis and the equilibrium, kinetic, relaxation and structural properties of two new GdIII-complexes based on modified 10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid (HP-DO3A) structure which, due to an intramolecular prototropic exchange, display more than two-fold higher relaxivity compared to currently available GdIII-based MRI contrast agents.